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Most newmutations are observed to arise in fathers, and increasing paternal age positively correlates with the risk of new variants. Inter-
estingly, newmutations in X-linked recessive disease show elevated familial recurrence rates. In male offspring, these mutations must be
inherited from mothers. We previously developed a simulation model to consider parental mosaicism as a source of transmitted muta-
tions. In this paper, we extend and formalize themodel to provide analytical results and flexible formulas. The results implicate parent of
origin and parental mosaicism as central variables in recurrence risk. Consistent with empirical data, our model predicts that more trans-
mittedmutations arise in fathers and that this tendency increases as fathers age. Notably, the lack of expansion later in themale germline
determines relatively lower variance in the proportion of mutants, which decreases with paternal age. Subsequently, observation of a
transmitted mutation has less impact on the expected risk for future offspring. Conversely, for the female germline, which arrests after
clonal expansion in early development, variance in the mutant proportion is higher, and observation of a transmittedmutation dramat-
ically increases the expected risk of recurrence in another pregnancy. Parental somatic mosaicism considerably elevates risk for both par-
ents. These findings have important implications for genetic counseling and for understanding patterns of recurrence in transmission
genetics. We provide a convenient online tool and source code implementing our analytical results. These tools permit varying the un-
derlying parameters that influence recurrence risk and could be useful for analyzing risk in diverse family structures.Introduction
New mutations are the sole source of disease risk for ge-
netic disorders that eliminate reproductive fitness and for
lethal alleles that can only exist in a mosaic state. Likewise,
newmutations account for approximately one-third of dis-
ease risk in severe X-linked recessive conditions that
diminish reproduction. In some instances, these new mu-
tations are mitotic in origin (they arise during embryologic
development of a parent) and are present in a low-level
mosaic state. Such mutations can include single-nucleo-
tide variations (SNVs), indels, nonrecurrent copy-number
variations (CNVs), and other nonrecurrent copy-number-
neutral structural variations.1 Importantly, these muta-
tions can be present in the germline of parents and
can be potentially recurrently transmitted to future
offspring.2–4 Unexpected recurrences can occur, as evi-
denced by multiple affected children harboring the same
apparently de novo variation. The birth of a single child
with a severe genetic disease presents considerable psycho-
logical, social, and economic challenges; consequently,
recurrence of the same disorder in a second child is a situ-
ation many couples prefer to avoid.5 Families who have
had children affected by apparently de novo mutations
can therefore benefit from well-informed risk counseling
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The Americaadditional pregnancies. These recurrence-risk estimates
are an important aspect of the health care provided to
such couples, particularly in severe and highly penetrant
genetic disorders for which medical therapy remains
limited.
Geneticists commonly use the value of <1% to estimate
the risk of recurrence for simplex de novomutations6 to be
transmitted to additional pregnancies. However, consider-
ation of the literature shows that this risk assessment is
often inconsistent with empirical risk for some specific dis-
orders,7 particularly those caused by mutations in genes
located on the X chromosome.8,9 These examples provide
insight into understanding exceptions to rarity of recur-
rence of apparently de novo mutations: males affected by
X-linked recessive conditions necessarily harbormutations
on the chromosome inherited from their mothers. This
maternal bias stands in contrast to the observations that
most new mutations arise in the paternal lineage and
that the risk of de novo mutation increases with paternal
age.10,11 This paternal bias is broadly consistent with the
mitotic origin of many de novo mutations and the addi-
tional mitoses experienced by germ cells as fathers age.
We hypothesized that sexual dimorphism in gametogen-
esis might underlie the juxtaposition of these contrasting
biases in higher recurrence risk for X-linked disease and
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Figure 1. Stochastic-Process Model of Sexual Dimorphisms dur-
ing Gametogenesis
Phase 1: both males and females experience a stochastic exponen-
tial cell-expansion phase modeling embryogenesis and germ cell
proliferation. Mutations can arise in any cell division, and if
they persist in the clonal lineage, they could ultimately be avail-
able to be transmitted to the next generation.
Phase 2: in males, expansion is followed by a stochastic but non-
expanding self-renewal process modeling spermatogenesis.
Phase 3: a single sperm and egg are randomly sampled after
meiosis to fertilize an offspring. Adapted from Campbell et al.4
with permission.mutations. To address this hypothesis, we developed a
comprehensive, flexible mathematical model that de-
scribes the emergence of new transmitted variants. We
show how recurrence risk can be computed on the basis
of conditional probability analyses applied to these models
in the context of observed affected offspring. These ana-
lyses give a comprehensive picture of the emergence of
de novo variation and a systematic framework for quanti-
tative analysis of recurrence. The main conclusion of our
work is that the parent of origin and the presence of
parental somatic mosaicism are major determinants of
recurrence risk.Material and Methods
Models of Mutation and Germline Development
For our investigations, we utilized multitype Galton-Watson pro-
cesses to model gametogenesis. These approaches are well estab-
lished in probability theory and have been used for over a century;
however, they have seldom been used in statistical genetics. Previ-
ous studies of mosaicism led us to hypothesize that this modeling
framework could be useful in the analysis of sexual dimorphisms
in gametogenesis.4 Our model of gametogenesis is composed of
three stages (Figure 1). We can optionally include a fourth initial
stage that allows stochastic exponential growth without mutation
to exclude extremely early embryologic mutations that potentially
cause the somatically mosaic parent to be affected. In the first
stage of ourmainmodel, we consider clonal expansion that results
in the initial germ pool during embryogenesis. This expansion
phase is parameterized by three variables: the doubling rate of
wild-type cells (p), the doubling rate of mutant cells (q), and the
per-mitosis mutation rate (l1). In the second male-specific stage,346 The American Journal of Human Genetics 95, 345–359, Octoberwe consider the self-renewing process of spermatogenesis. This
phase is relatively stable in terms of the total population size
and is parameterized by five variables: the doubling rate of wild-
type spermatogonial cells (a), the self-renewal rate of wild-type
cells (b), the doubling rate of mutant spermatogonial cells (g),
the self-renewal rate of mutant cells (x), and the per-mitosis muta-
tion rate (l2). The final phase is meiosis, where diploid mutant
cells give rise to haploid mutant gametes at a rate of 50% of the
pool of mutant cells. We then select a single gamete from each
parent to determine transmission.
We previously developed exact formulas for analyzing single-
phase Galton-Watson models.12 Here, we extended these sam-
pling formulas to encompass themultistage process (see Appendix
A). In brief, this approach requires composition of the output of
each prior phase and the subsequent phase. We determined an
exact integral expression for the mean and variance of the propor-
tion of cells with mutations at a particular locus within a parent’s
germ pool on the basis of the probability generating functions of
the composite process. We also developed a recursive computa-
tional scheme to numerically determine the required integrands.
Mathematica code implementing the formulas determined in
Appendix A is provided on our website.
However, for numbers of mitoses consistent with human devel-
opment, it is impractical to compute the number of terms in the
generating-function expansions. Furthermore, numerical integra-
tion approaches based on a finite grid break down well in advance
of useful numbers of mitoses. Therefore, we sought an alternative
method to determine model properties and recurrence-risk esti-
mates. We developed an exact matrix formulation for the first
two moments of the multistage Galton-Watson model (Appendix
B). We used these results and Taylor approximations for the mo-
ments of functions of random variables (in this case, a proportion)
to determine approximations of the mean and variance of the pro-
portion of mutants as a function of paternal age and other model
parameters (Appendix B).
Updating the expected proportion of mutants given the obser-
vation of a transmitted mutation is essential to determining recur-
rence risk. We used the definition of conditional probability to
determine an expression for the conditional expectation of the
proportion of mutants on the basis of the unconditional moments
of the proportion. Our results reveal that the conditional expecta-
tion of the proportion of mutants given an observed transmission
is equivalent to the size-biased mean of the proportion, a more
general mathematical result (Appendix C).
We subsequently explored the Beta-Binomial conjugate family13
as a useful and convenient Bayesian method to determine risk in
diverse family structures. We parameterized a Beta distribution
for the unconditional mean and variance of the proportion of mu-
tants by using the results from the Galton-Watson model. We
observed that the Beta-Binomial model gives exactly the same
result as that obtained by the size-biased mean of the proportion
of mutants for a single transmission. Therefore, we utilized the
Beta-Binomial model as a flexible and effective method to estimate
recurrence risk for arbitrary family sizes and the number of
affected and unaffected offspring. Notably, unaffected offspring
provide different information about the proportion of mutants
in the germ pool of the transmitting parent depending onwhether
or not they inherit the risk haplotype—the chromosome on
which the transmitted new mutation occurred. If haplotype
information is unavailable, the information for updating the
proportion is correspondingly diminished. Inheritance of the
nonrisk haplotype conveys almost no information. To incorporate02, 2014
Table 1. Selected Observed Recurrence Rates from the Literature
Disease (MIM) Inheritance Observations Recurrence Rate 95% Confidence Interval Reference
Achondroplasia (100800) autosomal dominant 443 0.2% 0.005%–1.3% Mettler and Fraser14
Osteogenesis imperfecta type II
(166210)
autosomal dominant 76 1.3% 0.03%–7.3% Pyott et al.7
Hemophilia A (306700) X-linked recessive 61 3.3% 0.4%–11.8% Leuer et al.9
Duchenne muscular dystrophy
(310200) and Becker muscular
dystrophy (300376)
X-linked recessive 318 8.6% 4.8%–12.2% Helderman-van den
Enden et al.8
Note that these data might reflect heterogeneous mutational mechanisms.this consideration when haplotype information was unavailable,
we computed a probability-weighted average recurrence risk by
summing across the binomial number of unaffected offspring
who share the risk haplotype with the affected individual and
assuming 50/50 segregation of parental homologs.
Finally, we considered the information gained from experi-
mental observation of somatic mosaicism in the parent of origin,
for example, from molecular studies of parental blood. Identifica-
tion of themutation in parental somatic tissue is evidence that the
mutation was present in the clonal lineage prior to the segregation
of the germline, which occurs at approximately 15 divisions.4 To
update the mutant proportion, we determined the expectation
and variance given that a nonzero number of mutants was present
in the parent before germ cell segregation (Appendix D).Results
Empirical Recurrence Rates
To motivate our work, we conducted a survey of the exist-
ing literature and examined the available empirical data.
Studies appropriately structured to address the issue
of empirical recurrence rates are sparse.8 Table 1 lists a
selection of studies with sufficient observations (n > 50
families) to attempt useful comparisons. Recurrence of
autosomal-dominant disease caused by new mutations ap-
pears to be rare. However, these data are most likely influ-
enced by average family size in cultures where biomedical
research has traditionally been undertaken. A second ma-
jor observation is that recurrence rates are apparently
higher for some sex-linked traits caused by mutations in
genes on the X chromosome (Table 1). To better contextu-
alize these observations, we sought to mathematically
model the process of germ cell formation.Model of Gametogenesis
Wepreviously developed a three-phase simulationmodel of
gamete formation and selection4 (Figure 1). Phase 1 deter-
mines the size of the germ cell pool and consists of an expo-
nential expansion occurring during 30 rounds of mitosis.
The approximate number of mitoses between generations
in human females is 30.15 According to our standard param-
eters for cellular fitness (Figure 2), this process defines
4.55 3 107 5 2.28 3 107 cells, a number approximately 1
order of magnitude higher than that identified in second-The Americatrimester human embryos,16 allowing for additional expan-
sion later in development. Phase 2 occurs only inmales and
represents the self-renewal process of spermatogenesis, dur-
ing which spermatogonial stem cells asymmetrically divide,
beginning at puberty, to produce sperm every 16 days.17
Phase 3 is meiosis and gamete selection, where 50% of gam-
etes are produced frommutant germ cells and one gamete is
randomly selected from each parent.
Risk of a First Affected Offspring
For our analyses, we considered each mitosis as equally
likely to result in a mutation, although our framework is
not limited in this regard. By varying the per-mitosis muta-
tion rate (l), we were able to effectively model mutations
that cause sporadic genetic diseases with a variety of prev-
alence rates. As an example, parameterizing l ¼ 1 3 1010
resulted in an expected proportion of offspring harboring a
mutation of 2.06 3 108 in a mating with a 30-year-old
male, which is consistent with previous estimates of hu-
man mutation rates per base pair per generation.18,19
Studies usingmassively parallel sequencing have identified
a strong paternal bias in the origin of new mutations,
which increases with age.10 Our modeling suggests that
additional mitoses during spermatogenesis are a potential
source of this bias, as previously hypothesized (Fig-
ure 2A).10 Because female gametes do not undergo mitosis
after birth, risk of SNVs and nonrecurrent CNVs is not pre-
dicted to vary with maternal age.10
Interestingly, the variance of theproportionofmutants is
relatively stable with paternal age. However, the expecta-
tion of the proportion is steadily increasing. Therefore,
the coefficient of variation, defined as the ratio of the stan-
dard deviation to the expectation, decreases as a father ages
(Figure 2B). This finding has direct consequences for recur-
rence risk aswe update our expectation of the proportion of
mutants on the basis of the observation of an affected child.
Recurrence Risk
Recurrence risk in the context of a new transmitted muta-
tion is defined as the chance that parents will have a sec-
ond child harboring the same DNA mutation as a previous
child. Analysis of recurrence risk must consider two
distinct underlying biological processes that can lead to
recurrence: (1) when a mutation arises and is maintainedn Journal of Human Genetics 95, 345–359, October 02, 2014 347
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A B Figure 2. Analysis of the Mean and Vari-
ance of the Unconditional Proportion of
Mutant Gametes
(A) Unconditional on the observation of an
affected offspring, the mean proportion of
mutant sperm and the expected risk of a
first affected offspring (the sum of sperm
and egg) are presented over various possible
paternal ages according to our model. Mu-
tation risk increases with paternal age.
(B)Coefficient of variationof theproportion
of mutant sperm as a function of paternal
age. Notably, the curve sharply decreases,
indicating that although the proportion of
mutant gametes increases, the variability
among fathers of a given age decreases in
relation to the mean. For these analyses,
we set l1 ¼ l2 ¼ 1 3 1010, p ¼ q ¼ 0.9,
a ¼ 0.05, b ¼ 0.05, g ¼ 0.05, and x ¼ 0.05
(see Material and Methods). An interactive
version of this analysis is available online.in the lineage of clonally related cells ancestral to a mutant
sperm or egg and (2) when an identical mutation arises
more than once within the developing germ cells across
multiple clonal sublineages. The contribution of the latter
is highly influenced by the per-mitosis mutation rate of the
given variant, but for most estimates of mutation rate, the
contribution of independent mutations to recurrence risk
is negligible. Therefore, our analysis of recurrence consid-
ered the clonal development, persistence, and selective
forces20 on germ cells and the propagation of mutations
within these clonal lineages.
Our results show that recurrence risk depends on the
parent of origin of the transmitted mutation. For mater-
nally transmitted mutations, recurrence risk is consider-
ably higher than empiric estimates for autosomal-domi-
nant conditions but is consistent with observations for
X-linked recessive disease (Tables 1 and 2). For paternally
transmitted mutations, recurrence risk is similar overall
to empirical risk estimates; however, the analyses revealed
that paternal age is an important variable modifying recur-
rence risk. For young fathers who transmit a mutant
gamete, recurrence risk is determined to be considerably
higher because sampling a mutant is more unexpected
and corresponds to a large increase in the expected risk
of additional transmission (Figure 3). However, recurrence
risk decreases with paternal age because observation of a
transmitted mutation is more consistent with the expected
increase in mutations in the paternal germ pool. In many
real-life situations, knowledge of the parent of origin of
new mutations is unavailable. In this circumstance, anal-
ysis of recurrence risk must consider the asymmetry in
the parent of origin of new mutations. In this case, we
calculate the recurrence risk by multiplying the sum of
the risk for each parent by the probability that the sampled
mutation was transmitted from that parent (Figure 3).
The birth of additional offspring, either affected or unaf-
fected, provides additional insight into the number of
mutant gametes in the germ pool of the transmitting
parent. Importantly, the information derived from unaf-348 The American Journal of Human Genetics 95, 345–359, Octoberfected offspring depends on the haplotype that they in-
herited from the transmitting parent. Inheriting the same
haplotype as the affected sibling but with a wild-type allele
provides information about the frequency of mutant
diploid germ cells. Inheritance of the haplotype from the
homologous parental chromosome provides almost no
information. Table 2 lists posterior recurrence-risk esti-
mates based on a Beta-Binomial Bayesian formulation
(see Material and Methods) for a number of potential fam-
ily structures. For transmitting mothers, the observation of
a second affected offspring raises the recurrence risk of a
third affected offspring to a potentially clinically action-
able level. However, for transmitting fathers, risk of a third
affected offspring is still less than 1% according to our
model. Surprisingly, when information of an unexpected
recurrence from an unknown parent is incorporated, the
paternal bias of new mutations disappears and each parent
is equally likely to have transmitted the mutation.
Parental Somatic Mosaicism and Recurrence Risk
Somaticmosaicism is the presence of amutation in a subset
of body tissues other than, or in addition to, the germ-
line.21 Our previous studies suggest that parental somatic
mosaicism for transmittedmutations (at least for nonrecur-
rent CNV alleles) is more common than previously identi-
fied and occurs at a rate of ~4%.4 Detecting somatic mosa-
icism in a transmitting parent—for example, in peripheral
blood—provides information regarding the timing of a
mutation because the germline becomes segregated from
the rest of the embryo within the first 15 mitoses.22,23 Ac-
cording to our analysis, compared to mutations for which
no information is known, mutations that are also somati-
cally mosaic in the transmitting parent are twice as likely
to recur for mothers and, surprisingly, 513 more likely to
recur in 30-year-old fathers (Table 2). For most reasonable
mutation rates and paternal ages, somatically mosaic par-
ents of either sex are at roughly equivalent risks of recur-
rence. Although definitively determining that mutant cells
are exclusively confined to the parental germline is not02, 2014
Table 2. Selected Recurrence-Risk Estimates Calculated from Our Analyses
Parent Age
Mosaic in
Blood
Recurrence-Risk Estimates
Risk Haplotype Unknown Haplotype
One Affected and
Zero Unaffected
One Affected and
One Unaffected
Two Affected and
Zero Unaffected
Three Affected and
Zero Unaffected
One Affected and
One Unaffected
Mother any unknown 2.60% 2.48% 4.95% 7.07% 2.54%
Father 20 unknown 0.235% 0.234% 0.468% 0.699% 0.235%
Father 25 unknown 0.142% 0.142% 0.28% 0.42% 0.142%
Father 30 unknown 0.102% 0.102% 0.203% 0.305% 0.102%
Father 35 unknown 0.080% 0.079% 0.159% 0.238% 0.080%
Father 40 unknown 0.065% 0.065% 0.130% 0.195% 0.065%
Father 50 unknown 0.048% 0.048% 0.096% 0.143% 0.048%
Unknown 30 unknown 0.197% – – – –
Unknown 50 unknown 0.094% – – – –
Mother any yes 5.21% 4.72% 9.40% 12.9% 4.96%
Father any yes 5.21% 4.72% 9.40% 12.9% 4.96%
Information gained about recurrence risk from observation of unaffected offspring depends on the chromosome haplotype inherited from the parent who trans-
mitted the mutant allele to the affected offspring. Inheriting the chromosome on which the mutation occurred (the risk haplotype) but with a wild-type allele
provides much more information than inheriting the homologous chromosome’s haplotype. Absence of evidence of somatic mosaicism is treated as unknown
because only a subset of tissue can be tested. Updating recurrence risk on the basis of additional offspring for an unknown transmitting parent is not considered
in this manuscript. We caution against using this model-based table directly in clinical practice.experimentally feasible, our analyses suggest that recur-
rence risk for such parents is 2–3 orders of magnitude lower
than that for parents with mutations that occurred before
the segregation of the germline.Recurrence-Risk Calculator
Tomake our analyses more accessible, we developed an on-
line tool to explore how changes in parameters of the
model and parent of origin influence estimates of recur-
rence. The parameters used for Table 2 are provided as
the default. This tool is detailed in the Web Resources
and might help to conceptualize the complex interplay
among the factors that determine gametogenesis. None-
theless, across a wide parameter space, the major conclu-
sions remain: parent of origin and somatic mosaicism are
major determinants of recurrence risk.Discussion
Estimating recurrence risk is an important clinical concept
that directly affects the medical management and repro-
ductive choices of couples with children affected by ge-
netic disease. Geneticists and genetic counselors often
rely on empirical understanding of recurrence risk, but spe-
cific information is available for only the most common
and well-understood diseases. Thus, frequently, they can
only advise on the basis of experience with a broad spec-
trum of diseases and mutation types. Our analyses yield
new insights into recurrence and implicate the parent of
origin as a central variable in the analysis of risk, but weThe Americacaution against using these estimates directly in routine
clinical practice. Nonetheless, we have found that muta-
tions of maternal origin determine higher recurrence risk
than do paternal mutations. The analysis that underlies
this finding requires detailed consideration of the funda-
mental developmental processes that lead to the transmis-
sion of new mutations. A comprehensive mathematical
treatment of recurrence risk in humans is not available in
the literature, and the authoritative reference does not
consider the complexity of sampling stochastic clonal
expansion or spermatogonial self-renewal.24 Other studies
have considered the consequences of mosaicism (also
called ‘‘premeiotic clusters’’) but were directed more to-
ward the study of population genetics.3,25,26
Our model predictions are consistent with the unex-
plained observation of increased recurrence risk among
X-linked recessive diseases. This elevated recurrence risk
is not a feature of a special choice of parameters in our
model but is instead a result of the structural difference
in gametogenesis between the sexes. For females, muta-
tions during the clonal-expansion phase are rare, but the
observation of a transmitted mutation is a strong indica-
tion that the maternal germline is rich in mutant gametes.
In probabilistic terms, although the expected proportion
of mutants is quite small, the prior variance in the propor-
tion is quite large. Subsequently, the observation of a trans-
mitted mutation has considerable information to update
and increase the expected proportion of mutants in the
maternal germ pool.
The situation for males is different. According to our
model, and consistent with observations, the expectedn Journal of Human Genetics 95, 345–359, October 02, 2014 349
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Figure 3. Analysis of Recurrence Risk as a Function of Parent of
Origin and Paternal Age
Because oogenesis completes during embryogenesis, recurrence
risk of maternally transmitted mutations is not expected to vary
with maternal age. According to our model, recurrence risk of
paternally transmitted mutations steadily decreases with age,
despite an increasing risk of a first affected offspring. When the
parent of origin is unknown, the overall recurrence risk is the
probability-weighted sum of the recurrence risks for both parents.
An interactive version of this analysis is available online.proportion of mutants is higher in males and steadily in-
creases with age. However, our analyses show that the
coefficient of variation of this proportion of mutants is
modest and steadily decreases with paternal age. As such,
observation of a transmitted mutation does not shift the
expectation of the fraction of mutants in the sperm pool
as strongly as for female germ cells. Observation of a
transmitted mutation from the paternal side contains
comparatively less information to alter the expected risk
of recurrence.
Our model framework permits us to analyze the impact
of mosaicism on recurrence risk. Emerging evidence sug-
gests that parental somatic mosaicism for transmitted mu-
tations is more common than previously thought and
might have a clinically significant impact on recurrence
risk. Our results indicate that compared to observation of
a transmission alone, observation of somatic mosaicism
increases recurrence risk 2-fold in mothers and more
than 50-fold in fathers.
The conclusions of our model can be tested by analysis
of the parent of origin and parental mosaicism in families
where transmitted genetic disease is caused by new muta-
tions, including families with and without observed
recurrences. Although these analyses are not commonly
performed, our results suggest that identification of the
parent of origin is a key consideration for intrafamilial
recurrence risk. In the absence of genome-wide data that
permit phasing of the mutant allele, personalized assays350 The American Journal of Human Genetics 95, 345–359, Octobersuch as single-gene sequencing or customized PCR to
determine the parent of origin might be useful. Likewise,
parental somatic mosaicism can be molecularly identi-
fied,8 and techniques with improved sensitivity should
also be developed.
In addition to somatic-mosaicism status and parent of
origin, the type of mutation in question most likely influ-
ences the parameters determining recurrence risk. The so-
called ‘‘paternal-age effect’’ disorders20 provide particularly
prominent examples. The high prevalence of Apert syn-
drome is attributed to mutant spermatogonial stem cells
dividing more frequently than wild-type cells.17 Although
the analysis we present in the text does not address this
type of effect, our model and online explorer (see Web
Resources) have provisions to modify these parameters.
Likewise, some mutation types, such as CpG dinucleotide
transitions or CNVs, might occur at higher or lower rates
in spermatogonial stem cells or vary by sex. Moreover,
genetic diversity in individual parents might influence
mutation rate globally27 or for select mutation types dur-
ing mitosis, as has been observed for meiotic mutational
mechanisms.28 Our model can also accommodate inquiry
into these aspects of human variation.
We suggest that our modeling framework is flexible and
that our results are robust across many choices of parame-
ters of mutation rate and cellular fitness. However, our
modeling framework does not account for all sources of
new disease-causing mutations. Importantly, we do not
consider meiotic-originmutations, such as nondisjunction
events that mediate aneuploidy. As such, disorders such as
Down syndrome and other conditions associated with
increasing maternal age are not the focus of our work.
Other classes of deleterious mutations could cause recur-
rent disease under more complex patterns of inheritance.
Our modeling is focused on autosomal-dominant alleles,
in which a single copy of a mutant allele determines dis-
ease state. This model is also directly applicable for
computing recurrence risk for X-linked recessive disease.
In other unexpected recurrence situations involving new
mutations, disease occurs through compound heterozy-
gosity, in which a new mutation from one parent is
randomly paired with a nonfunctional recessive allele in-
herited from the other parent. In these situations, familial
recurrence rates would be half of what is predicted by our
model, given that disease recurrence requires the nonfunc-
tional familial allele from the other parent to also be trans-
mitted to the offspring. Although our analysis focused on
the inheritance of new mutations for couples, it might
also contribute to understanding apparent violations of
Mendelian expectations in some pedigrees.
In addition to their immediate applicability to recur-
rence risk of new mutations, our analytic results also
represent a technical advance in the theory of branch-
ing processes. We extend the exact sampling formulas
for multitype Galton-Watson processes to multiphase
models, which in this application permitted us to con-
sider both clonal-expansion and self-renewal phases of02, 2014
gametogenesis. This advancemight extend the application
of Galton-Watson models and sampling results to other
contexts in biology, such as population genetics or the
emergence of mutations in model organisms that can be
experimentally assayed.29 We also developed an inter-
esting result concerning the analysis of stochastic propor-
tions. We showed that sampling a rare particle updates
the expected proportion of that rare particle to the value
determined by the size-biased distribution of the propor-
tion. This general fact could have other uses in statistics
and probability.
Ourmodeling framework considers only two types, wild-
type and mutants. This simplifying choice is appropriate
for the analysis of recurrent transmission of an index mu-
tation within a family. We recognize that additional work
is required for considering the full spectrum of variation
that can emerge during clonal divisions and ultimately
be transmitted by gametes between generations. We
suggest that the basic structure of our model can be
extended to considering an arbitrary number of mutation
types. The framework of our model is to allow new mu-
tants to arise and reproduce starting from a parental cell
type. If we iterate this approach, allowing mutant cells
from our model to initiate additional compound mutant
lineages, then the basic mathematical structure as pre-
sented in Appendices A and B can be extended to consid-
ering arbitrary accumulation of mutations as well as back
mutation. Future work in this area could advance the un-
derstanding of clonal heterogeneity, potentially of use in
the study of malignancy.
Our results suggest that parent of origin and somatic-
mosaicism status have considerable utility to inform esti-
mation of recurrence risk. Our results naturally raise the
question, ‘‘should clinicians quote a value different than
<1%’’? Empirical evidence,8 together with our model, sug-
gests that for some clearly defined mutations, on average,
risk is considerably higher. Large-scale empirical studies
of parent of origin, parental somatic mosaicism, and muta-
tional mechanisms are required for fully understanding
recurrence risk. For any particular mutation, the interplay
between these contributory factors determines risk, but
their superposition makes it difficult to disentangle
them. Further modeling based on improved empirical
data would be an excellent approach. Nonetheless, we sug-
gest that for families most concerned about recurrence,
particularly those with younger fathers, investigations
into parent of origin and mosaicism can help to reassure,
improve family planning, or direct the potential use of pre-
implantation or prenatal genetic diagnostics.Appendix A: Exact Formulas for Mutant
Proportions in the Paternal Germline
A Two-Phase Model of Gametogenesis
This study considers sexual dimorphism in gametogenesis,
mosaicism, and the consequences of these phenomena forThe Americamutation transmission between parents and offspring.
Although we are considering diploid cells that precede
the formation of haploid gametes, we consider cells as a
whole rather than each homologous chromosome sepa-
rately. Under this scheme, a cell with at least one mutation
at a given locus is considered mutant, whereas a cell with
only wild-type copies of DNA at that locus is considered
wild-type. This simplification is reasonable for low muta-
tion rates because the chance that two identical variations
will arise on each of the homologs in a cellular lineage is
extremely low.
For a single locus, the dynamics of this process can be
modeled with only two types: wild-type and mutant. Our
previous work12 provides exact sampling formulas for a
single-phase two-type Galton-Watson model of clonal
expansion with mutation, and this model is suitable to
represent the female germline. Here, we extend our ana-
lyses to consider a two-stage, two-type Galton-Watson pro-
cess suitable to represent the male germline. By two-stage
we mean that the progeny distributions start according
to the clonal-expansion rules as used in our earlier work
but then switch at a fixed generation j from clonal expan-
sion to self-renewal, under which the overall population
size of the germ pool remains relatively stable. This self-
renewal process proceeds for n  j ¼ k generations. This
two-stage model of expansion followed by an extended
period of self-renewal reflects the characteristics of the
male germline. The formulas for the model initiated from
a single wild-type cell at generation 0 are presented below.
In what follows, we definewild-type cells as type 0 andmu-
tants as type 1.
Probability Generating Functions
The fundamental tool for analysis of Galton-Watson
branching processes is the probability generating function
(pgf). A pgf is a polynomial transformation used to repre-
sent a discrete probability distribution. The real valued ar-
guments to pgfs are ‘‘dummy variables,’’ where powers of
these arguments correspond to the possible values of the
discrete random variable whose distribution is being
analyzed. The coefficient of each polynomial term corre-
sponds to the probability that the random variable being
modeled takes on the values indexed in the exponents.
For instance, for a variable X taking on the values {0,1,2},
let f(u) be the pgf of X. We could write f(u) ¼ 0.25 þ
0.5u þ 0.25u2, indicating that X takes the value 0 with
probability 0.25, the value 1 with probability 0.5, and
the value 2 with probability 0.25. Joint distributions of
two or more random variables can be similarly modeled
with bivariate or multivariate pgfs. For instance, for the
pair of random variables X and Y, each taking on values
in {0,1,2}, we could write f(u,v) ¼ 0.25 þ 0.5uv þ 0.25u2,
modeling a bivariate distribution where the only allowed
values of the ordered pair (X,Y) are (0,0), (1,1), and (2,0)
and where (1,1) occurs with probability 0.5.
The benefit of this notation is that various properties of
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properties of the pgf. For instance, the distribution of sums
of independent discrete random variables can be analyzed
by products of pgfs, and for multitype branching pro-
cesses, function composition of the pgfs for the progeny
determines the distribution of the evolution of the process.Using pgfs in Our Two-Phase Model
In our previously published work,12 we defined progeny
pgfs for the clonal-expansion process. f0 represents the
offspring of a wild-type cell, and f1 is the pgf for the
offspring of a mutant cell. The bivariate pgfs for wild-
type (dummy variable u) andmutant cells (v) during clonal
expansion are the following:
f0ðu; vÞ ¼ 1 pþ pluv þ pð1 lÞu2 (Equation A1)
f1ðu; vÞ ¼ 1 qþ qv2: (Equation A2)
Wild-type cells double with probability p or expire with
no progeny with probability 1  p. Independently,
dividing wild-type cells could either produce two wild-
types with probability 1  l or give rise to one wild-type
and one mutant with probability l. Mutant cells can
only give rise to two additional mutants with probability
q or die without division with probability 1  q.
The process of spermatogonial self-renewal proceeds by
asymmetric cell division, in which spermatogonial cells
most often produce a single renewal cell and only rarely
double or expire with no progeny. As in clonal expansion,
mutant cells can give rise to mutants, whereas wild-types
can produce either wild-type or mutant offspring. We
define the pgfs for the self-renewal process as j0 for wild-
type and j1 for mutant spermatogonial cells:
j0ðu; vÞ ¼ 1 a bþ au2 þ blv þ bð1 lÞu
(Equation A3)
j1ðu; vÞ ¼ 1 g xþ gv2 þ xv: (Equation A4)
Wild-type spermatogonial cells self-renew with proba-
bility b(1  l), divide with probability a, and expire
with probability 1  a  b. They generate mutant sper-
matogonial cells with probability bl. Similarly, for mutant
spermatogonial cells, they self-renew with probability x,
divide with probability g, and expire with probability
1  g  x.
As discussed above, male germline gametogenesis can be
modeled by iterative composition of these progeny pgfs.
The two-stage process has a total pgf that combines the j-
fold compositions of the first-stage expansion process
with n  j ¼ k-fold composition of the second-stage self-
renewal process. As a reminder, we use the Greek letter f
for the first-stage expansion-phase pgf and the letter j
for the second-stage of self-renewal. By j
ðkÞ
0 we intend the
k-fold composition of the second-stage process starting
from a single wild-type cell, and f
ðjÞ
0 is the j-fold composi-
tion of the expansion phase; we use the subscript 1 for
the corresponding functions beginning from mutants.352 The American Journal of Human Genetics 95, 345–359, Octoberp
ðnÞ
0 represents the total pgf for the two-stage process start-
ing from a single wild-type cell, whereas p
ðnÞ
1 is the corre-
sponding function for a process initiated by a mutant:
p
ðnÞ
0 ðu; vÞ ¼ fðjÞ0

j
ðkÞ
0 ðu; vÞ;jðkÞ1 ðu; vÞ

(Equation A5)
p
ðnÞ
1 ðu; vÞ ¼ fðjÞ1

j
ðkÞ
0 ðu; vÞ;jðkÞ1 ðu; vÞ

: (Equation A6)
According to our prior work,12 if we let Z0n and Z
1
n be the
number of wild-type and mutant cells, respectively, at gen-
eration n, then the mean and variance of the proportion of
mutants in this two-stage process can be determined with
the first and second derivatives of the bivariate pgf. The
expression for the expected proportion of mutants is
E
"
Z1n
Z0n þ Z1n
jZ0n þ Z1n > 0
#
¼ 1
1 pðnÞ0 ð0;0Þ
Z 1
0
v
vv
p
ðnÞ
0 ðu; vÞ j u¼v¼sds:
(Equation A7)
A related expression involving second derivatives deter-
mines the variance. Applying the chain rule to consider
the first derivatives, we have
vp
ðnÞ
0
vv
ðu; vÞ ¼ vf
ðjÞ
0
vj
ðkÞ
0
vj
ðkÞ
0
vv
þ vf
ðjÞ
0
vj
ðkÞ
1
vj
ðkÞ
1
vv
(Equation A8)
vp
ðnÞ
1
vv
ðu; vÞ ¼ vf
ðjÞ
1
vj
ðkÞ
0
vj
ðkÞ
0
vv
þ vf
ðjÞ
1
vj
ðkÞ
1
vj
ðkÞ
1
vv
: (Equation A9)
The chain rule shows that the total derivative requires
determination of derivatives for both wild-type and
mutant cells in both the first- and second-stage processes.
Similarly, computing second derivatives, as required for
the variance determination, also depends on differenti-
ating both pgfs for both stages. The derivatives for the first
stage are available in our prior work. The derivatives for the
second-stage process are determined as follows:
j
ð0Þ
0 ðu; vÞ ¼ u (Equation A10)
j
ð1Þ
0 ðu; vÞ ¼ 1 a bþ au2 þ blv þ bð1 lÞu
(Equation A11)
vj
ð1Þ
0
vv
ðu; vÞ ¼ bl (Equation A12)
v2j
ð1Þ
0
vv2
ðu; vÞ ¼ 0 (Equation A13)
j
ðkÞ
0 ðu; vÞ ¼ 1 a bþ a

j
ðk1Þ
0 ðu; vÞ
2
þ bljðk1Þ1 ðu; vÞ
þ bð1 lÞjðk1Þ0 ðu; vÞ:
(Equation A14)
Suppressing (u,v) on the right-hand side, we have02, 2014
vj
ðkÞ
0
vv
ðu; vÞ ¼ 2a
"
j
ðk1Þ
0
vj
ðk1Þ
0
vv
#
þ bl vj
ðk1Þ
1
vv
þ bð1 lÞ vj
ðk1Þ
0
vv
(Equation A15)
v2j
ðkÞ
0
vv2
ðu; vÞ ¼ 2a
2
4jðk1Þ0 v2jðk1Þ0vv2 þ
 
vj
ðk1Þ
0
vv
!235þ bl v2jðk1Þ1
vv2
þ bð1 lÞ v
2j
ðk1Þ
0
vv2
:
(Equation A16)
And for mutants, we have
j
ð0Þ
1 ðu; vÞ ¼ v (Equation A17)
j
ð1Þ
1 ðu; vÞ ¼ 1 g xþ gv2 þ xv (Equation A18)
vj
ð1Þ
1
vv
ðu; vÞ ¼ 2gv þ x (Equation A19)
v2j
ð1Þ
1
vv2
ðu; vÞ ¼ 2g (Equation A20)
j
ðkÞ
1 ðu; vÞ ¼ 1 g xþ g

j
ðk1Þ
1
2
þ xjðk1Þ1
(Equation A21)
vj
ðkÞ
1
vv
ðu; vÞ ¼ 2gjðk1Þ1
vj
ðk1Þ
1
vv
þ x vj
ðk1Þ
1
vv
(Equation A22)
v2j
ðkÞ
1
vv2
ðu; vÞ ¼ 2g
2
4 vjðk1Þ1
vv
!2
þ jðk1Þ1
v2j
ðk1Þ
1
vv2
3
5þ x v2jðk1Þ1
vv2
:
(Equation A23)
To compute the integrands for the mean and variance
formulas, we first compute the inner function composition
for the second-stage self-renewal process and then use this
as the initial condition for evaluating the composition of
the first-stage clonal-expansion process. It is important to
note that evaluation of these function compositions pro-
ceeds from the ‘‘inside out’’; that is, the compositions pro-
ceed from the final generation of the process backward to-
ward ancestral cells and ultimately to the single wild-type
progenitor cell. The superscripts index the number of func-
tion compositions, but these compositions are computed
in the reverse order from the forward indexing of cell divi-
sion. Thus, it is important to track the j and k indices for a
fixed n. Recall that for a self-renewal process that proceeds
for k generations after j generations of clonal expansion,
n ¼ jþ k (Equation A24)
k ¼ 0:::ðn jÞ: (Equation A25)
To initialize the two-stage composition, we start with the
final round of clonal expansion, composed of the total
composition representing k generations of self-renewal:The Americap
ð1þkÞ
0 ðu; vÞ ¼ 1 pþ pljðkÞ0 ðu; vÞjðkÞ1 ðu; vÞ 2þ pð1 lÞ jðkÞ0 ðu; vÞ : (Equation A26)
Again suppressing (u,v) on the right-hand side, we have
vp
ð1þkÞ
0
vv
ðu; vÞ ¼ pl
"
vj
ðkÞ
0
vv
j
ðkÞ
1 þ jðkÞ0
vj
ðkÞ
1
vv
#
þ 2pð1 lÞjðkÞ0
vj
ðkÞ
0
vv
(Equation A27)
v2p
ð1þkÞ
0
vv2
ðu; vÞ ¼ pl
"
v2j
ðkÞ
0
vv2
j
ðkÞ
1 þ 2
vj
ðkÞ
0
vv
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ðkÞ
1
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þ jðkÞ0
v2j
ðkÞ
1
vv2
#
þ 2pð1 lÞ
2
4 vjðkÞ0
vv
!2
þ jðkÞ0
v2j
ðkÞ
0
vv2
3
5 :
(Equation A28)
Subsequently for j>1,
p
ðjþkÞ
0 ðu; vÞ ¼ 1 pþ plpðjþk1Þ0 pðjþk1Þ1 þ pð1 lÞ

p
ðjþk1Þ
0
2
(Equation A29)
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ðjþkÞ
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ðu; vÞ ¼ pl
"
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ðjþk1Þ
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ðjþk1Þ
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1
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þ 2pð1 lÞpðjþk1Þ0
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0
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(Equation A30)
v2p
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vv
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0
vv2
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(Equation A31)
Again for mutants,
p
ð1þkÞ
1 ðu; vÞ ¼ 1 qþ q

j
ðkÞ
1
2
(Equation A32)
vp
ð1þkÞ
1
vv
ðu; vÞ ¼ 2qjðkÞ1
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ðkÞ
1
vv
(Equation A33)
v2p
ð1þkÞ
1
vv2
ðu; vÞ ¼ 2q
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ðkÞ
1
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þ 2qjðkÞ1
v2j
ðkÞ
1
vv2
(Equation A34)
p
ðjþkÞ
1 ðu; vÞ ¼ 1 qþ q

p
ðjþk1Þ
1
2
(Equation A35)
vp
ðjþkÞ
1
vv
ðu; vÞ ¼ 2qpðjþk1Þ1
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ðjþk1Þ
1
vv
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v2p
ðjþkÞ  
vp
ðjþk1Þ!2
v2p
ðjþk1Þ1
vv2
ðu; vÞ ¼ 2q 1
vv
þ 2qpðjþk1Þ1 1vv2 :
(Equation A37)
Recursive Scheme for Pointwise Function Evaluation
Expansion of the polynomials defined above by recursive
function composition proves impractical. As in our previ-
ous work,12 we developed a recursive scheme for point-
wise function evaluation to permit numerical evaluation
of the integrand for determining the exact mean and vari-
ance of the mutant proportion. We define this notation
here:
HkðsÞ ¼ jðkÞ0 ðs; sÞ; hkðsÞ ¼
vj
ðkÞ
0
vv
ðu; vÞ j u¼v¼s; hhkðsÞ
¼ v
2j
ðkÞ
0
vv2
ðu; vÞ j u¼v¼s
(Equations A38)
MkðsÞ ¼ jðkÞ0 ðs; sÞ; mkðsÞ ¼
vj
ðkÞ
1
vv
ðu; vÞ j u¼v¼s; mmkðsÞ
¼ v
2j
ðkÞ
1
vv2
ðu; vÞ j u¼v¼s
(Equations A39)
FjðsÞ ¼ fðjÞ0 ðs; sÞ; fjðsÞ ¼
vf
ðjÞ
0
vv
ðu; vÞ j u¼v¼s; ffjðsÞ
¼ v
2f
ðjÞ
0
vv2
ðu; vÞ j u¼v¼s
(Equations A40)
GjðsÞ ¼ fðjÞ0 ðs; sÞ; gjðsÞ ¼
vf
ðjÞ
1
vv
ðu; vÞ j u¼v¼s; ggjðsÞ
¼ v
2f
ðjÞ
1
vv2
ðu; vÞ j u¼v¼s:
(Equations A41)
We obtain the following recursive scheme:
HkðsÞ ¼ 1 a bþ aH2k1ðsÞ þ blMk1ðsÞ þ bð1 lÞHk1ðsÞ
(Equation A42)
hkðsÞ ¼ 2a½Hk1ðsÞhk1ðsÞ þ blmk1ðsÞ þ bð1 lÞhk1ðsÞ
(Equation A43)
hhkðsÞ ¼ 2a
h
Hk1ðsÞhhk1ðsÞ þ h2k1ðsÞ
i
þ blmmk1ðsÞ
þ bð1 lÞhhk1ðsÞ
(Equation A44)
MkðsÞ ¼ 1 g xþ gM2k1ðsÞ þ xMk1ðsÞ (Equation A45)
mkðsÞ ¼ 2gMk1ðsÞmk1ðsÞ þ xmk1ðsÞ (Equation A46)354 The American Journal of Human Genetics 95, 345–359, OctobermmkðsÞ ¼ 2g

m2k1ðsÞ þMkk1ðsÞmmk1ðsÞ
þ xmmk1ðsÞ
(Equation A47)
FjðsÞ ¼ 1 pþ plFj1ðsÞGj1ðsÞ þ pð1 lÞF2j1ðsÞ
(Equation A48)
fjðsÞ ¼ pl
h
fj1ðsÞGj1ðsÞ þ Fj1ðsÞgj1ðsÞ
i
þ 2pð1 lÞFj1ðsÞfj1ðsÞ (Equation A49)
ffjðsÞ ¼ pl
h
ffj1ðsÞGj1ðsÞ þ 2fj1ðsÞgj1ðsÞ þ Fj1ðsÞggj1ðsÞ
i
þ 2pð1 lÞ
h
f 2j1ðsÞ þ Fj1ðsÞffj1ðsÞ
i
(Equation A50)
GjðsÞ ¼ 1 qþ qG2j1ðsÞ (Equation A51)
gjðsÞ ¼ 2qGj1ðsÞgj1ðsÞ (Equation A52)
ggjðsÞ ¼ 2q
h
g2j1ðsÞ þ Gj1ðsÞggj1ðsÞ
i
: (Equation A53)
The initial conditions are
H1ðsÞ ¼ 1 a bþ as2 þ bs (Equation A54)
h1ðsÞ ¼ bl (Equation A55)
hh1ðsÞ ¼ 0 (Equation A56)
M1ðsÞ ¼ 1 g xþ gs2 þ xs (Equation A57)
m1ðsÞ ¼ 2gsþ x (Equation A58)
mm1ðsÞ ¼ 2g (Equation A59)
F1ðsÞ ¼ 1 pþ pH2k ðsÞ (Equation A60)
f1ðsÞ ¼ pl½hkðsÞMkðsÞ þHkðsÞmkðsÞ þ 2pð1 lÞHkðsÞhkðsÞ
(Equation A61)
ff1ðsÞ ¼ pl½hhkðsÞMkðsÞ þ 2hkðsÞmkðsÞ þHkðsÞmmkðsÞ
þ 2pð1 lÞ
h
h2kðsÞ þHkðsÞhhkðsÞ
i
(Equation A62)
G1ðsÞ ¼ 1 qþ qM2k ðsÞ (Equation A63)
g1ðsÞ ¼ 2qMkðsÞmkðsÞ (Equation A64)
gg1ðsÞ ¼ 2qm2kðsÞ þ 2qMkðsÞmmkðsÞ: (Equation A65)
For the female line composed of only clonal expansion,
the initial conditions are02, 2014
F1ðsÞ ¼ 1 pþ ps2 (Equation A66)
f1ðsÞ ¼ pls (Equation A67)
ff1ðsÞ ¼ 0 (Equation A68)
G1ðsÞ ¼ 1 qþ qs2 (Equation A69)
g1ðsÞ ¼ 2qs (Equation A70)
gg1ðsÞ ¼ 2q: (Equation A71)
Mathematica code implementing these recurrences can
be found on our website. We note that the spermatogonial
self-renewal model can be extended to allow mutation at
spermatogonial division:
j0ðu; vÞ ¼ 1 a bþ ð1 lÞau2 þ lauv þ blv þ bð1 lÞu:
(Equation A72)
We elected not to use this form for two reasons: (1) the
main dynamics of the model are not substantively
altered, and (2) we wished to conform with the simu-
lation model used in our previously published work.4
Likewise, l can be modeled to take on different values
in the two phases of gametogenesis or vary by generation
of cell division.Appendix B: Taylor Approximations to the
Moments of the Proportion of Mutants
Calculating the numerical integration of the formulas pre-
sented in Appendix A proves difficult. Approximations
of the mean and variance of the proportion of mutants
can be obtained with Taylor approximations of the mo-
ments of functions of random variables. In order to apply
these approximations, we require the mean, variance,
and covariance of the number of wild-type and mutant
cells in each generation. In this problem, there are seven
fundamental parameters that are determined from the
progeny pgfs, and these are given in Table B1 below:Table B1. Model Parameter Determined by the Progeny
Generating Function
Parameter Description
m00 expected wild-types born to a wild-type
m01 expected mutants born to a wild-type
m11 expected mutants born to a mutant
s200 variance of wild-types born to a wild-type
s201 variance of mutants born to a wild-type
s211 variance of mutants born to a mutant
r01 the expectation of the product of the number of
wild-types and mutants born to a wild-type
The AmericaImportantly, the key structure of the model—where mu-
tants can give additional mutants but wild-types make
wild-types or mutants—is unchanged between the
clonal-expansion and self-renewal phases. Depending on
the previous generation, a single homogenous, linear
recurrence in five-state variables determines the two
means, the two variances, and the covariance of the num-
ber of wild-type and mutant cells in each generation. Spec-
ifying the initial state (the number of wild-type and
mutant cells at the first generation) and the values of the
parameters described above determines the evolution of
the process. Let Z0n be the number of wild-type cells in gen-
eration n and Z1n be the number of mutants at n. Let
Zn ¼ ðZ0n;Z1nÞt . We obtain
E

Z0n
 ¼ EEZ0n jZ0n1 ¼ u00EZ0n1 (Equation B1)
V

Z0n
 ¼ EVZ0n jZ0n1þ VEZ0n jZ0n1
¼ EZ0n1s200 þ m200VZ0n1: (Equation B2)
Similarly, for Z1n we have
E

Z1n
 ¼ EEZ1n jZ0n1;Z1n1 ¼ u01EZ0n1þ u11EZ1n1
(Equation B3)
V

Z1n
 ¼ VEZ1n jZ0n1;Z1n1þ EVZ1n jZ0n1;Z1n1
¼ s201E

Z0n1
þ m201VZ0n1þ s211EZ1n1
þ m211V

Z1n1

:
(Equation B4)
Finally, for the covariance, we have this identity:
Cov

Z0n;Z
1
n
 ¼ ECovZ0n;Z1n jZn1
þ CovEZ0n jZn1; EZ1n jZn1
¼ ðr01  m00m01ÞE

Z0n1
þ m00m01VZ0n1
þ m00m11Cov

Z0n1;Z
1
n1

:
(Equation B5)
Examining these recurrence formulas for generation
n, we observe that they are homogeneous, first-order
linear recurrences that depend only on the values of
the previous generation, n  1. Therefore, we can
simplify and write a matrix expression for the vector:
bn ¼ ðE½Z0n;V ½Z0n;E½Z1n;V ½Z1n;Cov½Z0n;Z1nÞt .
bn ¼ Abn1 (Equation B6)
A ¼
2
66664
m00 0 0 0 0
s200 m
2
00 0 0 0
m01 0 m11 0 0
s201 m
2
01 s
2
11 m
2
11 0
ðr01  m00m01Þ m00m01 0 0 m00m11
3
77775
(Equation B7)
Because the two phases share the form A, we can deter-
mine the evolution of the two-phase process by matrixn Journal of Human Genetics 95, 345–359, October 02, 2014 355
multiplication initializing from a single wild-type cell in
generation 0. Let A1 be the matrix for phase 1 and A2 be
the matrix for phase 2. Then,
bn ¼ Ak2Aj1
2
66664
1
0
0
0
0
3
77775: (Equation B8)
Using the parameters of the pgfs, we can determine the
values of the seven parameters that define the two phases
(Table B2):Table B2. Expressions Determining the Model Parameters
Parameter Phase 1 Phase 2
m00 p(2  l) 2a þ b(1  l)
s200 4p(1  p)  3pl
 2p2l  p2l2
4a(1  a) þ b(1  l)
(1  b(1  l))  4ab(1  l)
m01 pl bl
s201 pl(1  pl) bl(1  bl)
m11 2q 2g þ x
s211 4q(1  q) 4g(1  g) þ x(1  x)  4gx
r01 pl 0We point out that
Cov

Z1n;Z
0
n þ Z1n
 ¼ CovZ1n;Z0nþ VZ1n (Equation B9)
V

Z0n þ Z1n
 ¼ VZ1nþ VZ0nþ 2CovZ1n;Z0n:
(Equation B10)
And therefore, using Taylor approximations, we can
approximate the moments of the proportion of mutants:
E
"
Z1n
Z1n þ Z0n
jZ0n þ Z1n > 0
#
z
E

Z1n

E

Z0n þ Z1n
 Cov

Z1n;Z
0
n þ Z1n

E

Z0n þ Z1n
2
þ E

Z1n

E

Z0n þ Z1n
3 VZ0n þ Z1n
(Equation B11)
V
"
Z1n
Z1n þ Z0n
jZ1n þ Z0n > 0
#
z
V

Z1n

E

Z0n þ Z1n
2  2E

Z1n

E

Z0n þ Z1n
3
3Cov

Z1n;Z
0
n þ Z1n

þ E

Z1n
2
E

Z0n þ Z1n
4 VZ0n þ Z1n:
(Equation B12)
R code implementing the above approximations as well
as an interactive exploration tool that uses these approxi-
mations can be found on our website. These expressions
can also be adjusted to account for potential mutation in
spermatogonial division, as described in Appendix A.356 The American Journal of Human Genetics 95, 345–359, OctoberAppendix C: A Size-Biased Result for Updating the
Expected Mutant Proportion
To obtain the conditional mean of the proportion of
mutants given the observation of a transmitted mutation,
we apply the definition of conditional expectation. We
note that there are many biological constraints, but for
analysis of this model, transmission can only occur when
Z1n > 0 and subsequently when Z
0
n þ Z1n > 0. Let qn ¼ Z1n=
ðZ0n þ Z1nÞ, X represent the number of transmitted muta-
tions observed, and y be a dummy variable that represents
the possible proportions of mutants for a given parent:
E½qn jX ¼ 1 ¼
X
y
yP½qn ¼ y jX ¼ 1¼
X
y
y
P½X ¼ 1 j qn ¼ yP½qn ¼ y
P½X ¼ 1 :
(Equation C1)
For a single Bernoulli trial, we note
P½X ¼ 1 j qn ¼ y ¼ y: (Equation C2)
Unconditionally, we note
P½X ¼ 1 ¼ E½P½X ¼ 1 j qn ¼ E½qn : (Equation C3)
Therefore,
E½qn jX ¼ 1 ¼ 1
P½X ¼ 1
X
y
y2P½qn ¼ y ¼
E
h
ðqnÞ2
i
E½qn ;
(Equation C4)
which we notice is the mean of the size-biased distribution
of qn. For clarity, E½ðqnÞ2 ¼ V ½qn þ ðE½qnÞ2.
Accounting for meiosis to determine the proportion of
mutant haploid gametes, a factor of one-half appears in
both the numerator and the denominator of these expres-
sions. These factors cancel and therefore do not appear.
R code implementing the above expressions can be found
on our website.Appendix D: Updating Risk on the Basis of
Observation of Parental Somatic Mosaicism
Observation of the mutant allele in parental somatic tis-
sues—for example, by amplification with PCR or other
methods—represents important information for updating
the expected proportion of mutants, which we equate
with the risk of recurrence. To analyze the change in the
expected proportion of mutants, we reason that observa-
tion of the transmitted mutation in parental somatic tis-
sues gives information about the nonzero state of the
number of mutants in the parent of origin at generation
i. Here, i represents the cell-division number when the
germline becomes sequestered from the portion of the
embryo that will give rise to the somatic tissues. We
note that i < j, where j is the generation when the02, 2014
clonal-expansion phase of gametogenesis ends. In our
work, we set i ¼ 15, consistent with the reported litera-
ture.22,23 To complete our analysis, we first consider the
conditional expectations given the state of mutants at i
without conditioning on observation of a transmission
from parent to child. According to the law of total
expectation,
E½qn ¼ E

qn jZ1i ¼ 0

P

Z1i ¼ 0
þ Eqn jZ1i > 0PZ1i > 0:
(Equation D1)
The term E½qnjZ1i > 0 is the quantity we seek to compute.
E[qn] is available from the Taylor approximation, and we
can compute the probability of 0 mutants in generation i
by evaluating fi0ð1;0Þ by using the i-fold composition of
Equation A1. Therefore, if we can determine E½qnjZ1i ¼ 0,
we can determine the required result:
E

qn jZ1i > 0
 ¼ E½qn  E

qn jZ1i ¼ 0

P

Z1i ¼ 0

P

Z1i > 0
 :
(Equation D2)
We take a similar approach to the variance. However, the
variance is necessarily more complex and requires consid-
eration of the result from the conditional mean analysis.
The analysis requires V½E½qnjIZ1
i
¼0, where I is an indicator
that the number of mutant cells at generation i is 0.
Subsequently,
V
h
E
h
qn j IZ1
i
¼0
ii
¼ Eqn jZ1i ¼ 02PZ1i ¼ 0
þ Eqn jZ1i > 02PZ1i > 0
 Eqn jZ1i ¼ 0PZ1i ¼ 0
þ Eqn jZ1i > 0PZ1i > 02
¼ Eqn jZ1i ¼ 02PZ1i ¼ 0
þ Eqn jZ1i > 02PZ1i > 0 E½qn2:
(Equation D3)
We then use this fact to consider the conditional vari-
ance identity:
V ½qn ¼ E
h
V
h
qn j IZ1
i
¼0
ii
þ V
h
E
h
qn j IZ1
i
¼0
ii
¼ Vqn jZ1i ¼ 0PZ1i ¼ 0þ Vqn jZ1i > 0PZ1i > 0
þ V
h
E
h
qn j IZ1
i
¼0
ii
:
(Equation D4)
Therefore,
V

qn jZ1i > 0

¼
V½qnV
h
E
h
qn j IZ1
i
¼0
ii
Vqn jZ1i ¼0PZ1i ¼ 0
P

Z1i > 0
 :
(Equation D5)
On the basis of the results above, we have both
E½qnjZ1i > 0 and V ½qnjZ1i > 0. The key quantities to beThe Americaapproximated are E½qnjZ1i ¼ 0 and V ½qnjZ1i ¼ 0. Then,
using the expressions above and calculating PðZ1i ¼ 0Þ
from the appropriate pgf, we are able to determine the
updated expected mutant proportion. Let Z be a random
variable with the same distribution as the number of
wild-types cells when there are no mutants at i (that is,
Z¼d Z0i
Z1i ¼ 0). Let S0ni;m and S1ni;m be random variables
that count the number of wild-type and mutant particles,
respectively, at generation n and descend from the mth
wild-type particle present at generation i. We proceed as
follows:
E

qn jZ1i ¼ 0
 ¼ EEqn jZ1i ¼ 0;Z
¼ E
" PZ
m¼1S
1
ni;mPZ
m¼1S
1
ni;mþ
PZ
m¼1S
0
ni;m
#
z
E
hPZ
m¼1S
1
ni;m
i
E
hPZ
m¼1S
1
ni;mþ
PZ
m¼1S
0
ni;m
i

Cov
hPZ
m¼1S
1
ni;m;
PZ
m¼1S
0
ni;m þ
PZ
m¼1S
1
ni;m
i
E
hPZ
m¼1S
1
ni;m þ
PZ
m¼1S
0
ni;m
i2
þ
E
hPZ
m¼1S
1
ni;m
i
E
hPZ
m¼1S
1
ni;mþ
PZ
m¼1S
0
ni;m
i3 VhXZm¼1S1ni;mþXZm¼1S0ni;m
i
:
(Equation D6)
And for clarity,
E½Z ¼ EZ0i jZ1i ¼ 0zEZ0i þ EZ1i  (Equation D7)
V ½Z ¼ VZ0i jZ1i ¼ 0zVZ0i þ VZ1i  (Equation D8)
E
"X
m¼1
Z
S0ni;m
#
¼ E½ZE
h
S0ni;m
i
(Equation D9)
E
"X
m¼1
Z
S1ni;m
#
¼ E½ZE
h
S1ni;m
i
(Equation D10)
V
"X
m¼1
Z
S0ni;m
#
¼ E½ZV
h
S0ni;m
i
þ E
h
S0ni;m
i2
V½Z
(Equation D11)
V
"X
m¼1
Z
S1ni;m
#
¼ E½ZV
h
S1ni;m
i
þ E
h
S1ni;m
i2
V½Z
(Equation D12)
V
"X
m¼1
Z
S0ni;m þ
X
m¼1
Z
S1ni;m
#
¼ V
"X
m¼1
Z
S0ni;m
#
þ V
"X
m¼1
Z
S1ni;m
#
þ 2,Cov
"X
m¼1
Z
S0ni;m;
X
m¼1
Z
S1ni;m
#
:
(Equation D13)
Using the identity for the covariance of random sums as
used in Equation B5, we haven Journal of Human Genetics 95, 345–359, October 02, 2014 357
Cov
"X
m¼1
Z
S1ni;m;
X
m¼1
Z
S0ni;m þ
X
m¼1
Z
S1ni;m
#
¼ Cov
"X
m¼1
Z
S0ni;m;
X
m¼1
Z
S1ni;m
#
þ V
"X
m¼1
Z
S1ni;m
#
¼ E½ZCovS0ni; S1niþ V½ZEhS0ni;miEhS1ni;mi
þ E½ZV
h
S1ni;m
i
þ E
h
S1ni;m
i2
V ½Z:
(Equation D14)
We can use the results from Appendix B to determine
these moments, giving us the values required for calcu-
lating Equation D2. A similar approximation is available
for the variance:
V

qn jZ1i ¼ 0

z
V
hPZ
m¼1S
1
ni;m
i
V
hPZ
m¼1S
1
ni;m þ
PZ
m¼1S
0
ni;m
i

2,E
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1
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1
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m¼1S
0
ni;m
i3
3Cov
hXZ
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1
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XZ
m¼1S
0
ni;mþ
XZ
m¼1S
1
ni;m
i
þ
E
hPZ
m¼1S
1
ni;m
i2
E
hPZ
m¼1S
1
ni;m þ
PZ
m¼1S
0
ni;m
i4
3V
hXZ
m¼1S
1
ni;m þ
XZ
m¼1S
0
ni;m
i
:
(Equation D15)
This expression along with the moments expressions in
Appendix B gives us the values to calculate Equation D5.
With the results of Equations D2 and D5, we again use
the size-biasing result presented in Appendix C to update
the risk given both observed transmission and the pres-
ence of the mutation in parental somatic tissues. In brief,
E

qn jZ1i > 0;X ¼ 1
 ¼ E

q2n jZ1i > 0

E

qn jZ1i > 0
 : (Equation D16)
R code implementing the calculations using the for-
mulas above and approximations fromAppendix B is avail-
able on our website.Acknowledgments
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